Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Somatostatinoma × tipifarnib × 90 days × Clear all

Sponsor

Conditions

Neuroblastoma 2 Xanthogranuloma, Juvenile 1 Wilms Tumor 1 Squamous Cell Carcinoma of Head and Neck 1 Sarcoma, Ewing 1 Sarcoma 1 Rhabdomyosarcoma 1 Rhabdoid Tumor 1 Recurrence 1 Osteosarcoma 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Medulloblastoma 1 Lymphoma, Non-Hodgkin 1 Histiocytosis, Langerhans-Cell 1 Histiocytic Sarcoma 1 Hereditary Sensory and Autonomic Neuropathies 1 Hepatoblastoma 1 Head and Neck Neoplasms 1 Glioma 1 Ependymoma 1 Central Nervous System Neoplasms 1

Interventions

Temozolomide 2 Capecitabine 2 Specimen Handling 1 Nivolumab 1 Magnetic Resonance Spectroscopy 1 Ipilimumab 1 Etoposide 1 Cisplatin 1 Carboplatin 1 CTLA-4 Antigen 1 11-(2-methylpropyl)-12,13-dihydro-2-methyl-8-(pyrimidin-2-ylamino)-4H-indazolo(5,4-a)pyrrolo(3,4-c)carbazol-4-one 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡